400 related articles for article (PubMed ID: 32308746)
21. Circulating nuclear DNA structural features, origins, and complete size profile revealed by fragmentomics.
Sanchez C; Roch B; Mazard T; Blache P; Dache ZAA; Pastor B; Pisareva E; Tanos R; Thierry AR
JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33571170
[TBL] [Abstract][Full Text] [Related]
22. 'Longing' for the Next Generation of Liquid Biopsy: The Diagnostic Potential of Long Cell-Free DNA in Oncology and Prenatal Testing.
Yu SCY; Choy LYL; Lo YMD
Mol Diagn Ther; 2023 Sep; 27(5):563-571. PubMed ID: 37474843
[TBL] [Abstract][Full Text] [Related]
23. The role and diagnostic value of cell-free DNA in systemic lupus erythematosus.
Truszewska A; Foroncewicz B; Pączek L
Clin Exp Rheumatol; 2017; 35(2):330-336. PubMed ID: 27908304
[TBL] [Abstract][Full Text] [Related]
24. A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications.
Volckmar AL; Sültmann H; Riediger A; Fioretos T; Schirmacher P; Endris V; Stenzinger A; Dietz S
Genes Chromosomes Cancer; 2018 Mar; 57(3):123-139. PubMed ID: 29205637
[TBL] [Abstract][Full Text] [Related]
25. Usefulness and reliability of cell free fetal DNA screening for main trisomies in case of atypical profile on first trimester maternal serum screening.
Carrara J; Vivanti A; Jani JC; Demain A; Costa JM; Benachi A
J Transl Med; 2019 Nov; 17(1):398. PubMed ID: 31779618
[TBL] [Abstract][Full Text] [Related]
26.
Serpas L; Chan RWY; Jiang P; Ni M; Sun K; Rashidfarrokhi A; Soni C; Sisirak V; Lee WS; Cheng SH; Peng W; Chan KCA; Chiu RWK; Reizis B; Lo YMD
Proc Natl Acad Sci U S A; 2019 Jan; 116(2):641-649. PubMed ID: 30593563
[TBL] [Abstract][Full Text] [Related]
27. Identifying the tissues-of-origin of circulating cell-free DNAs is a promising way in noninvasive diagnostics.
Peng X; Li HD; Wu FX; Wang J
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32427285
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Single Molecule, Real-Time Sequencing and Nanopore Sequencing for Analysis of the Size, End-Motif, and Tissue-of-Origin of Long Cell-Free DNA in Plasma.
Yu SCY; Deng J; Qiao R; Cheng SH; Peng W; Lau SL; Choy LYL; Leung TY; Wong J; Wong VW; Wong GLH; Jiang P; Chiu RWK; Chan KCA; Lo YMD
Clin Chem; 2023 Feb; 69(2):168-179. PubMed ID: 36322427
[TBL] [Abstract][Full Text] [Related]
29. The Long and Short of Circulating Cell-Free DNA and the Ins and Outs of Molecular Diagnostics.
Jiang P; Lo YMD
Trends Genet; 2016 Jun; 32(6):360-371. PubMed ID: 27129983
[TBL] [Abstract][Full Text] [Related]
30. Could high levels of cell-free DNA in maternal blood be associated with maternal health and perinatal outcomes?
Konuralp Atakul B; Koc A; Adiyaman D; Kuyucu M; Sahingoz Yildirim AG; Saka Guvenc M; Erdogan KM; Sengul B; Oztekin DC
J Obstet Gynaecol; 2020 Aug; 40(6):797-802. PubMed ID: 31769709
[TBL] [Abstract][Full Text] [Related]
31. The Combining Effects of Cell-Free Circulating Tumor DNA of Breast Tumor to the Noninvasive Prenatal Testing Results: A Simulating Investigation.
Cai YH; Yao GY; Chen LJ; Gan HY; Ye CS; Yang XX
DNA Cell Biol; 2018 Jul; 37(7):626-633. PubMed ID: 29957029
[TBL] [Abstract][Full Text] [Related]
32. Clinical algorithm model based on cfDNA to predict SLE disease activity.
Wang F; Liu YJ; Miao HB; Chen Z
Lupus; 2024 Feb; 33(2):145-154. PubMed ID: 38183242
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy.
Gai W; Sun K
Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30634483
[TBL] [Abstract][Full Text] [Related]
34. Systematic biases in reference-based plasma cell-free DNA fragmentomic profiling.
Liu X; Yang M; Hu D; An Y; Wang W; Lin H; Pan Y; Ju J; Sun K
Cell Rep Methods; 2024 Jun; 4(6):100793. PubMed ID: 38866008
[TBL] [Abstract][Full Text] [Related]
35. Incidental Detection of Maternal Neoplasia in Noninvasive Prenatal Testing.
Dharajiya NG; Grosu DS; Farkas DH; McCullough RM; Almasri E; Sun Y; Kim SK; Jensen TJ; Saldivar JS; Topol EJ; van den Boom D; Ehrich M
Clin Chem; 2018 Feb; 64(2):329-335. PubMed ID: 28982650
[TBL] [Abstract][Full Text] [Related]
36. cfDNA deconvolution via NIPT of a pregnant woman after bone marrow transplant and donor egg IVF.
Zhu J; Hui F; Mao X; Zhang S; Qi H; Du Y
Hum Genomics; 2021 Feb; 15(1):14. PubMed ID: 33622405
[TBL] [Abstract][Full Text] [Related]
37. A method for improving the accuracy of non-invasive prenatal screening by cell-free foetal DNA size selection.
He QZ; Wu XJ; He QY; Xiang JJ; Zhang CH; Lu L; Wang T; Li H
Br J Biomed Sci; 2018 Jul; 75(3):133-138. PubMed ID: 29968522
[TBL] [Abstract][Full Text] [Related]
38. Applications of genetic-epigenetic tissue mapping for plasma DNA in prenatal testing, transplantation and oncology.
Gai W; Zhou Z; Agbor-Enoh S; Fan X; Lian S; Jiang P; Cheng SH; Wong J; Chan SL; Jang MK; Yang Y; Liang RH; Chan WK; Ma ES; Leung TY; Chiu RW; Valantine H; Chan KA; Lo YD
Elife; 2021 Mar; 10():. PubMed ID: 33752803
[TBL] [Abstract][Full Text] [Related]
39. [Innovative Prenatal Testing: Clinical Applications and Ethical Considerations].
Huang MC; Lin SJ; Chen CL; Huang TJ
Hu Li Za Zhi; 2017 Oct; 64(5):5-10. PubMed ID: 28948585
[TBL] [Abstract][Full Text] [Related]
40. Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies.
Lo YMD; Han DSC; Jiang P; Chiu RWK
Science; 2021 Apr; 372(6538):. PubMed ID: 33833097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
